Form 4: Eli Lilly Director Juan R. Luciano Acquires Shares Under Directors' Deferral Plan

Sentiment:

SEC Form 4 Filing


Director Juan R. Luciano acquired 17.985 shares of Eli Lilly & Co common stock at $824.76 per share on March 17, 2025, under the company's Directors' Deferral Plan.

Summary

  • On March 17, 2025, Juan R. Luciano, a director of Eli Lilly & Co, acquired 17.985 shares of common stock.
  • The shares were acquired at a price of $824.76 per share.
  • The acquisition was made under the Lilly Directors' Deferral Plan, where shares are deferred in lieu of cash compensation.
  • These shares will be settled in common stock following Luciano's separation from service.
  • Following the transaction, Luciano directly owns 16,276.053 shares of Eli Lilly & Co.
  • The transaction was reported on March 19, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a director's continued investment in the company, which is generally viewed favorably, but it's a routine transaction.

Positives

  • The acquisition reflects Luciano's continued investment in Eli Lilly & Co.
  • The Directors' Deferral Plan allows directors to align their interests with the long-term performance of the company.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's prospects. This transaction reflects a director's continued investment in the company.

Comparison to Industry Standards

  • Director share acquisitions are a common practice in publicly traded companies, often used as a form of compensation and to align director interests with shareholder value.
  • Similar deferral plans are offered by companies like Pfizer (PFE) and Johnson & Johnson (JNJ) to their directors.

Stakeholder Impact

  • The transaction signals confidence from a director, which can positively influence shareholder sentiment.

Key Dates

DateDescription
03/17/2025Date of transaction: Juan R. Luciano acquired shares of Eli Lilly & Co.
03/19/2025Date of report filing.

Keywords

Eli Lilly, Director, Share Acquisition, Directors' Deferral Plan, Common Stock, Luciano, LLY

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.